Human dNK cell function is differentially regulated by extrinsic cellular engagement and intrinsic activating receptors in first and second trimester pregnancy

Cellular and Molecular Immunology

Volumn 14, Issue 2, 2017, Pages 203-213

  Zhang, Jianhong ^a   Dunk, Caroline E ^a,b   Kwan, Melissa ^a,b   Jones, Rebecca L ^c,d   Harris, Lynda K ^c,d   Keating, Sarah ^b   Lye, Stephen J ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 8; LYMPHOCYTE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL P80 RELATED PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG; VASCULOTROPIN; KLRF1 PROTEIN, HUMAN; KLRK1 PROTEIN, HUMAN; LECTIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NATURAL KILLER CELL RECEPTOR; VASCULOTROPIN A;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; DECIDUAL NATURAL KILLER CELL; DEGRANULATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; NATURAL KILLER CELL; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; TROPHOBLAST; UPREGULATION; ANGIOGENESIS; CELL COMMUNICATION; CYTOLOGY; DECIDUA; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; PHENOTYPE; PREGNANCY;

CELL COMMUNICATION; DECIDUA; FEMALE; HUMANS; INTERLEUKIN-8; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE COUNT; NEOVASCULARIZATION, PHYSIOLOGIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PHENOTYPE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RECEPTORS, NATURAL KILLER CELL; TROPHOBLASTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85011805343     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.66     Document Type: Article

References (56)

1. King A, Burrows T, Verma S, Hiby S, Loke YW. Human uterine lymphocytes. Hum Reprod Update 1998; 4: 480-485.
2. Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ 2004; 329: 1283-1285.
3. Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 2009; 174: 1959-1971.
4. Bulmer JN, Lash GE. Human uterine natural killer cells: A reappraisal. Mol Immunol 2005; 42: 511-521.
5. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065-1074.
6. Moffett A, Colucci F. Uterine NK cells: Active regulators at the maternal-fetal interface. J Clin Invest 2014; 124: 1872-1879.
7. Fu B, Li X, Sun R, Tong X, Ling B, Tian Z et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 2013; 110: E231-E240.
8. Williams PJ, Searle RF, Robson SC, Innes BA, Bulmer JN. Decidual leucocyte populations in early to late gestation normal human pregnancy. J Reprod Immunol 2009; 82: 24-31.
9. Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol 2010; 54: 281-294.
10. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44-49.
11. Wang F, Zhou Y, Fu B, Wu Y, Zhang R, Sun R et al. Molecular signatures and transcriptional regulatory networks of human immature decidual NK and mature peripheral NK cells. Eur J Immunol 2014; 44: 2771-2784.
12. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198: 1201-1212.
13. Male V, Sharkey A, Masters L, Kennedy PR, Farrell LE, Moffett A. The effect of pregnancy on the uterine NK cell KIR repertoire. Eur J Immunol 2011; 41: 3017-3027.
14. Marlin R, Duriez M, Berkane N, de Truchis C, Madec Y, Rey-Cuille M-A et al. Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy. PLoS One 2012; 7: e30017.
15. El Costa H, Casemayou A, Aguerre-GirrM, Rabot M, Berrebi A, Parant O et al. Critical and differential roles of NKp46-And NKp30-Activating receptors expressed by uterine NK cells in early pregnancy. J Immunol 2008; 181: 3009-3017.
16. Vacca P, Pietra G, Falco M, Romeo E, Bottino C, Bellora F et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006; 108: 4078-4085.
17. Co EC, Gormley M, Kapidzic M, Rosen DB, Scott MA, Stolp HAR et al. Maternal decidual macrophages inhibit NK cell killing of invasive cytotrophoblasts during human pregnancy. Biol Reprod 2013; 88: 1-9.
18. Vacca P, Moretta L, Moretta A, Mingari MC. Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol 2011; 32: 517-523.
19. Robson A, Harris LK, Innes BA, Lash GE, AljunaidyMM, Aplin JD et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 2012; 26: 4876-4885.
20. Vacca P, Cantoni C, Prato C, Fulcheri E, Moretta A, Moretta L et al. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int Immunol 2008; 20: 1395-1405.
21. Karimi K, Arck PC. Natural Killer cells: keepers of pregnancy in the turnstile of the environment. Brain Behav Immun 2010; 24: 339-347.
22. Zhang J, Chen Z, Smith GN, Croy BA. Natural killer cell-Triggered vascular transformation: maternal care before birth? Cell Mol Immunol 2011; 8: 1-11.
23. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The Great Obstetrical Syndromes are associated with disorders of deep placentation. Am J Obstet Gynecol 2011; 204: 193-201.
24. Romero R, Kusanovic JP, Kim CJ. Placental bed disorders in the genesis of the great obstetrical syndromes. In: Pijnenborg R, Brosens I, Romero R (eds.) Placental Bed Disorders. Cambridge: Cambridge University Press, 2010: 271-289.
25. Wallace AE, Whitley GS, Thilaganathan B, Cartwright JE. Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia. J Leukoc Biol 2015; 97: 79-86.
26. Wallace AE, Fraser R, Gurung S, Goulwara SS, Whitley GS, Johnstone AP et al. Increased angiogenic factor secretion by decidual natural killer cells from pregnancies with high uterine artery resistance alters trophoblast function. Hum Reprod 2014; 29: 652-660.
27. Yokoyama WM, Sojka DK, Peng H, Tian Z. Tissue-resident natural killer cells. Cold Spring Harb Symp Quant Biol 2014; 78: 149-156.
28. Sojka DK, Plougastel-Douglas B, Yang L, Pak-Wittel MA, Artyomov MN, Ivanova Y et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenicNKcells. eLife 2014; 3: e01659.
29. Graham CH, Hawley TS, Hawley RC, MacDougall JR, Kerbel RS, Khoo N et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993; 206: 204-211.
30. Wallace A, Fraser R, Cartwright J. Extravillous trophoblast and decidual natural killer cells: A remodelling partnership. Hum Reprod Update 2012; 18: 458-471.
31. Dennehy KM, Klimosch SN, Steinle A. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. J Immunol 2011; 186: 657-661.
32. Deguine J, Breart B, Lemaitre F, Bousso P. Cutting edge: Tumortargeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell-Tumor cell interactions. J Immunol 2012; 189: 5493-5497.
33. Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013; 31: 227-258.
34. Klimosch SN, Bartel Y, Wiemann S, Steinle A. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses. Blood 2013; 122: 2380-2389.
35. Apps R, Sharkey A, Gardner L, Male V, Kennedy P, Masters L et al. Ex vivo functional responses to HLA-G differ between blood and decidual NK cells. Mol Hum Reprod 2011; 17: 577-586.
36. Cohnen A, Chiang SC, Stojanovic A, Schmidt H, Claus M, Saftig P et al. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-Associated damage. Blood 2013; 122: 1411-1418.
37. Brenner CD, King S, Przewoznik M, Wolters I, Adam C, BornkammGW et al. Requirements for control of B-cell lymphoma by NK cells. Eur J Immunol 2010; 40: 494-504.
38. Reiners KS, Topolar D, Henke A, Simhadri VR, Kessler J, Sauer M et al. Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-Tumor activity. Blood 2013; 121: 3658-3665.
39. HuY, Dutz JP, MacCalmanCD, Yong P, TanR, vonDadelszenP.Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: A role for IFN-c. J Immunol 2006; 177: 8522-8530.
40. Wang F, Zhou Y, Fu B, Wu Y, Zhang R, Sun R et al. Molecular signatures and transcriptional regulatory networks of human immature decidual NK and mature peripheral NK cells. Eur J Immunol 2014; 44: 2771-2784.
41. Sotnikova N, Voronin D, Antsiferova Y, Bukina E. Interaction of decidual CD561 NK with trophoblast cells during normal pregnancy and recurrent spontaneous abortion at early term of gestation. Scand J Immunol 2014; 80: 198-208.
42. Arck PC, Hecher K. Fetomaternal immune cross-Talk and its consequences for maternal and offsprings health. Nat Med 2013; 99: 548-556.
43. Hazan AD, Smith SD, Jones RL, Whittle W, Lye SJ, Dunk CE. Vascularleukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Am J Pathol 2010; 177: 1017-1030.
44. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27: 939-958.
45. Zhang J, Dunk CE, Lye SJ. Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration. Hum Reprod 2013; 28: 3026-3037.
46. Apps R, Gardner L, Traherne J, Male V, Moffett A. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum Reprod 2008; 23: 2535-2548.
47. Hedlund M, Stenqvist A-C, Nagaeva O, Kjellberg L, Wulff M, Baranov V et al. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol 2009; 183: 340-351.
48. Xiong S, Sharkey AM, Kennedy PR, Gardner L, Farrell LE, Chazara O et al. Maternal uterine NK cell-Activating receptor KIR2DS1 enhances placentation. J Clin Invest 2013; 123: 4264-4272.
49. Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E et al. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005; 106: 1711-1717.
50. Manaster I, Mandelboim O. The unique properties of uterine NK cells. Am J Reprod Immunol 2010; 63: 434-444.
51. Coudert JD, Scarpellino L, Gros F, Vivier E, Held W. SustainedNKG2D engagement induces cross-Tolerance of multiple distinct NK cell activation pathways. Blood 2008; 111: 3571-3578.
52. Le Bouteiller P. Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies. Front Immunol 2013; 4: 404.
53. Fauriat C, Long EO, Ljunggren H-G, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010; 115: 2167-2176.
54. Newman KC, Riley EM. Whatever turns you on: Accessory-celldependent activation of NK cells by pathogens. Nat Rev Immunol 2007; 7: 279-291.
55. Sojka DK, Tian Z, Yokoyama WM. Tissue-resident natural killer cells and their potential diversity. Semin Immunol 2014; 26: 127-131.
56. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 2013; 31: 413-441.